CytomX Therapeutics

New generation of fully recombinant, protease-activated monoclonal antibodies that can achieve unprecedented levels of tissue-specific targeting.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of CytomX Therapeutics plus 5594 other startups.

Start Free 7 Day Trial Now

Learn More About CytomX Therapeutics

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

Competing Startups


Companies We Work With